X0306 4 2020-06-18 false 0001603756 Axonics Modulation Technologies, Inc. AXNX 0001756438 Dearen Danny L. 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false See Remarks Common Stock 2020-06-18 4 M false 27749.00 1.42 A 84240.00 D Common Stock 2020-06-18 4 M false 2251.00 1.32 A 86491.00 D Common Stock 2020-06-18 4 S false 30000.00 39.2627 D 56491.00 D Common Stock 2020-06-22 4 M false 2015.00 1.42 A 58506.00 D Common Stock 2020-06-22 4 M false 8890.00 1.32 A 67396.00 D Common Stock 2020-06-22 4 M false 34095.00 1.63 A 101491.00 D Common Stock 2020-06-22 4 S false 45000.00 38.1106 D 56491.00 D Stock Option (Right to Buy) 1.42 2020-06-18 4 M false 27749.00 0.00 D 2027-08-25 Common Stock 27749.00 16895.00 D Stock Option (Right to Buy) 1.32 2020-06-18 4 M false 2251.00 0.00 D 2027-07-05 Common Stock 2045.00 17067.00 D Stock Option (Right to Buy) 1.63 2020-06-22 4 M false 34095.00 0.00 D 2028-03-30 Common Stock 34095.00 35505.00 D Stock Option (Right to Buy) 1.42 2020-06-22 4 M false 2015.00 0.00 D 2027-08-25 Common Stock 2015.00 14880.00 D Stock Option (Right to Buy) 1.32 2020-06-22 4 M false 8890.00 0.00 D 2027-05-22 Common Stock 8890.00 8177.00 D This sale was pursuant to a 10b5-1 plan adopted by the reporting person on March 23, 2020. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 21, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 21, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. President, Chief Financial Officer /s/ Danny L. Dearen 2020-06-19